Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the translocation of chromosomes 9 and 22, consequently expressing the fusion oncogene BCR-ABL, which results in constitutive tyrosine kinase activity [1–3]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.